Free Trial

Nephros (NEPH) SEC Filings & 10K Form

Nephros logo
$1.64 +0.04 (+2.19%)
As of 12:15 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Nephros SEC Filings

DateFilerForm TypeView
03/24/2025
10:13 AM
Nephros (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/03/2025
5:13 PM
Amron Arthur H (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:03 PM
Nephros (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:15 PM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:18 PM
Nephros (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/30/2024
3:35 PM
Amron Arthur H (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:05 PM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
11:15 PM
Nephros (Filer)
Form EFFECT
05/16/2024
3:29 PM
Amron Arthur H (Reporting)
Nephros (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
7:00 AM
Nephros (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:10 PM
Nephros (Filer)
Form ARS
04/12/2024
3:10 PM
Nephros (Filer)
Form ARS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:NEPH) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners